Identification of a biological signature for schizophrenia in serum
2011 · Molecular Psychiatry · 221 citations
https://doi.org/10.1038/mp.2011.42
F
F. Markus Leweke
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
235
Papers
13.3K
Citations
60
h-index
147
i10-index
F. Markus Leweke is an academic researcher from The University of Sydney. The author has contributed to research in topics: Cannabis and Cannabinoid Research & Tryptophan and brain disorders & Schizophrenia research and treatment. The author has an h-index of 60, co-authored 200 publications.
ORCID: 0000-0002-8163-195XPapers by this author
worksCannabis and psychiatric disorders: it is not only addiction
2008 · Addiction Biology · 215 citations
https://doi.org/10.1111/j.1369-1600.2008.00106.x
Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression
2007 · Journal of Neural Transmission · 183 citations
https://doi.org/10.1007/s00702-007-0660-5
Serum proteomic profiling of major depressive disorder
2015 · Translational Psychiatry · 134 citations
https://doi.org/10.1038/tp.2015.88
Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways
2013 · Schizophrenia Bulletin · 98 citations
https://doi.org/10.1093/schbul/sbt105
Towards a blood-based diagnostic panel for bipolar disorder
2015 · Brain Behavior and Immunity · 60 citations
https://doi.org/10.1016/j.bbi.2015.10.001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat